Literature DB >> 3924215

Therapeutic ranges in anticoagulant administration.

L Poller.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3924215      PMCID： PMC1416105          DOI： 10.1136/bmj.290.6483.1683

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  16 in total

1.  Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction.

Authors:  T C Chalmers; R J Matta; H Smith; A M Kunzler
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

2.  Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis.

Authors:  D A Taberner; L Poller; R W Burslem; J B Jones
Journal:  Br Med J       Date:  1978-02-04

3.  Progress in laboratory control of oral anticoagulants.

Authors:  E A Loeliger; S M Lewis
Journal:  Lancet       Date:  1982-08-07       Impact factor: 79.321

4.  Anticoagulants in coronary heart disease--retrospect and prospect.

Authors:  J R Mitchell
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

5.  A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.

Authors:  J C Forfar
Journal:  Br Heart J       Date:  1979-08

6.  Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.

Authors:  R Hull; T Delmore; E Genton; J Hirsh; M Gent; D Sackett; D McLoughlin; P Armstrong
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

7.  Dosage and control of oral anticoagulants: an international collaborative survey.

Authors:  L Poller; D A Taberner
Journal:  Br J Haematol       Date:  1982-07       Impact factor: 6.998

8.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

9.  Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction.

Authors:  J W Kennedy; J L Ritchie; K B Davis; J K Fritz
Journal:  N Engl J Med       Date:  1983-12-15       Impact factor: 91.245

10.  Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

Authors:  R Hull; T Delmore; C Carter; J Hirsh; E Genton; M Gent; G Turpie; D McLaughlin
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245
View more
  9 in total

1.  Safety of anticoagulation in the elderly: reasons for discontinuing therapy.

Authors:  P A O'Neill; D Crossley; D A Taberner; D S Fairweather
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

Review 2.  The Smith Kline & French lecture 1987. Clinical pharmacology and the art of bespoke prescribing.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 3.  Control of warfarin therapy.

Authors:  D K Scott
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

4.  Warfarin and cataract extraction.

Authors:  G A Robinson; A Nylander
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

5.  Control of oral anticoagulant treatment by chromogenic prothrombin assay.

Authors:  J R O'Donnell; I D Walker; J F Davidson
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

6.  The effects of lower intensity anticoagulation therapy on coagulation system in patients with mechanical prosthetic valves.

Authors:  X Du; K Zhang; Z Hu; H Lan; J Luo; Y Jin
Journal:  J Tongji Med Univ       Date:  1999

7.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

8.  Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.

Authors:  Joana C Santos; Juliana M F Mesquita; Celso L R Belmiro; Carolina B M da Silveira; Christian Viskov; Pierre A Mourier; Mauro S G Pavão
Journal:  Thromb Res       Date:  2007-05-04       Impact factor: 3.944

9.  Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses.

Authors:  H Oxenham; P Bloomfield; D J Wheatley; R J Lee; J Cunningham; R J Prescott; H C Miller
Journal:  Heart       Date:  2003-07       Impact factor: 5.994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.